UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): January 12, 2007

BIO-KEY INTERNATIONAL, INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware
(State or Other Jurisdiction of Incorporation)

1-13463

 

41-1741861

(Commission File Number)

 

(IRS Employer Identification No.)

 

 

 

3349 Highway 138, Building D, Suite B, Wall, NJ

 

07719

(Address of Principal Executive Offices)

 

(Zip Code)

 

732-359-1100
(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 




 

Item 8.01.                Other Events.

Attached hereto as Exhibit 99.1 is the registrant’s advertisement, published in the Toronto Globe and Mail on January 17, 2007 relating to its plans to make an exchange offer for all of the issued and outstanding shares of ComnetiX Inc (TSE:CXI).

ITEM 9.01.   FINANCIAL STATEMENTS AND EXHIBITS.

     (d)       Exhibits.

Exhibit Number

 

Description

 

 

 

99.1

 

BIO-Key International, Inc. Advertisement of Offer, as published in the Toronto Globe and Mail on January 17, 2007, relating to the offer by the Company to acquire all of the outstanding common shares of Comnetix.

 

2




 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

BIO-KEY INTERNATIONAL, INC.

 

 

 

 

 

By:

/s/ Francis J. Cusick

 

 

Francis J. Cusick

 

 

Chief Financial Officer

 

 

 

Dated: January 17, 2007

 

 

3